These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34936287)

  • 1. Overexpression of IncRNA SAMMSON Promotes Triple-Negative Breast Cancer Cell Proliferation by Interacting with p53.
    Xing Z; Zhang M; Liu J; Liu G; Feng K; Wang X
    Crit Rev Eukaryot Gene Expr; 2021; 31(6):1-8. PubMed ID: 34936287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-526b targets lncRNA SLC16A1-AS1 to suppress cell proliferation in triple-negative breast cancer.
    Zhao X; Fu L; Zhai L; Yang X; Gao R
    J Biochem Mol Toxicol; 2023 Mar; 37(3):e23247. PubMed ID: 36654514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
    Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
    J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis.
    Song X; Liu Z; Yu Z
    Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):386-392. PubMed ID: 30839051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
    Wang N; Hou M; Zhan Y; Sheng X
    J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.
    Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ
    J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MCM3AP-AS1 Downregulates LncRNA MEG3 in Triple Negative Breast Cancer to Inhibit the Proliferation of Cancer Cells.
    Ren G; Han G; Song Z; Zang A; Liu B; Hu L; Jia L; Hong D; Yang L; Qie S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):81-87. PubMed ID: 34587438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
    Sun E; Liu X; Lu C; Liu K
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC.
    Niu L; Fan Q; Yan M; Wang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MRPS30 divergent transcript can be detected in the cytoplasm of triple-negative breast cancer cells and is targeted by microRNA-130b.
    Wang D; Song Q; Zhao T; Wang F; Yu Y; Qi J; Lyu P; Duan X
    Bioengineered; 2022 Mar; 13(3):5954-5961. PubMed ID: 35191803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.
    Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y
    Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
    Yan J; Wang R; Wu Z
    J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
    Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA
    Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis.
    Bai X; Zhang S; Qiao J; Xing X; Li W; Zhang H; Xie J
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.
    Wang J; Xi C; Yang X; Lu X; Yu K; Zhang Y; Gao R
    Cancer Biother Radiopharm; 2019 Dec; 34(10):671-675. PubMed ID: 31621381
    [No Abstract]   [Full Text] [Related]  

  • 20. The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma.
    Ghasemian M; Babaahmadi-Rezaei H; Khedri A; Selvaraj C
    J Cell Mol Med; 2023 Dec; 27(24):3966-3973. PubMed ID: 37772815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.